Form 4: Biogen Executive Rachid Izzar Reports Stock Transactions

Rachid Izzar, Head of Global Product Strategy at Biogen, reports the acquisition and disposal of Biogen common stock and restricted stock units on February 7, 2025.

Summary

• On February 7, 2025, Rachid Izzar, Head of Global Product Strategy at Biogen, reported transactions involving Biogen's common stock and restricted stock units.
• Izzar acquired 2,043 shares of common stock through the vesting of restricted stock units and disposed of 600 shares to cover tax obligations at a price of $141.35.
• An additional 565 shares were disposed of at $141.35.
• Izzar also acquired 1,801 shares of common stock through the vesting of additional restricted stock units.
• Following these transactions, Izzar directly owns 6,059 shares of Biogen common stock.
• Izzar also owns 2,044 restricted stock units that vest annually starting February 8, 2023, and 3,604 restricted stock units that vest annually starting February 7, 2024.

Sentiment

Score: 5

Explanation: This is a neutral report on stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel and their holdings in the company.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent routine insider trading activity.

Key Dates

Keywords

Biogen, BIIB, Rachid Izzar, stock, restricted stock units, Form 4, insider trading